The 2nd Transparency and Aggregate Spend Summit provides the latest information needed to meet Open Payments, State, and Global transparency reporting requirements. Gain strategies for managing high risk HCP interactions, data integrity and putting transparency data to work. This is an excellent opportunity to get the knowledge and networking you need to compliantly report HCP spend and build valuable transparency programs. Attendees will have the opportunity to assess the tools and strategies currently being implemented to ensure complete and accurate data and identify compliance risks.
Topics covered will include:
- Examine trends in enforcement of PhRMA Code changes
- Understand the requirements and implications of CA Assembly Bill 1278
- Benchmark implementation strategies for the Italian Sunshine Law
- Gain best practices for putting transparency data to work using CMS published data
- Gain an outline of guidelines and timelines for global transparency reporting
Those working for pharmaceutical, biotechnology and medical device companies working in:
- Compliance
- Ethics
- Legal
- Transparency
- Global Transparency
- Global Compliance
- Reporting
- Aggregate Spend
- Data analytics
- Monitoring and auditing
- Systems/IT
- Finance
- Accounting
- Government
- Monitor the updates to Open Payments, State and Global transparency regulations and guidelines
- Manage the process for record review, remediation and compliance monitoring
- Use transparency data analytics to pinpoint risks and avoid potential enforcement action
- Manage the risks involved in HCP engagement
- Improve compliance auditing and monitoring
Stay up to date on the latest announcements